Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1

Biochemistry, Genetics and Molecular Biology

• Gene Fusion 100%
• KDM2A 100%
• Genetics 20%
• Gene Expression Profiling 20%
• Reverse Transcription Polymerase Chain Reaction 20%
• Epigenetics 20%
• Immunoreactivity 20%
• RNA Sequence 20%
• Fusion Gene 20%
• Histone Modification 20%
• Rosette Formation 20%

Medicine and Dentistry

• Neoplasm 100%
• Gene Fusion 100%
• Histone Modification 10%
• RNA Sequence 10%
• Reverse Transcription Polymerase Chain Reaction 10%
• Skin 10%
• Immunoreactivity 10%
• Index Case 10%
• Stroma 10%
• Subcutaneous Tissue 10%
• Elbow 10%
• Sarcoma 10%
• Gene Expression Profiling 10%
• Fusion Gene 10%
• Epithelioid Cell 10%
• Axillary Mass 10%
• Rosette Formation 10%